0001520138-23-000053.txt : 20230118
0001520138-23-000053.hdr.sgml : 20230118
20230118162152
ACCESSION NUMBER: 0001520138-23-000053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221123
FILED AS OF DATE: 20230118
DATE AS OF CHANGE: 20230118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PEIZER TERREN S
CENTRAL INDEX KEY: 0000904534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39015
FILM NUMBER: 23534680
MAIL ADDRESS:
STREET 1: 11111 SANTA MONICABLVD STE.500
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOVIE INC.
CENTRAL INDEX KEY: 0001580149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462510769
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
BUSINESS PHONE: 775-888-3162
MAIL ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
FORMER COMPANY:
FORMER CONFORMED NAME: NANOANTIBIOTICS, INC.
DATE OF NAME CHANGE: 20130625
4
1
ownership.xml
X0306
4
2022-11-23
0
0001580149
BIOVIE INC.
BIVI
0000904534
PEIZER TERREN S
C/O ACUITAS GROUP HOLDINGS, LLC
2001 WILSHIRE BLVD #330
LOS ANGELES
CA
90403
1
0
1
0
STOCK OPTION (RIGHT TO BUY)
6.12
2022-11-23
4
A
0
65000
0
A
2032-11-23
COMMON STOCK
65000
65000
D
Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan.
The options vest in four equal installments over a one-year period ending November 9, 2023.
/S/ TERREN PEIZER
2023-01-13